Meeting
2022 ASCO Annual Meeting
Patient-reported outcomes for measuring the quality of life in advanced breast cancer treated with third-line and beyond chemotherapy-based regimens: A national cross-sectional study.
Authors
Xiuwen Guan
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Xiuwen Guan , Xiaoyan Yan , Ying Wang , Xichun Hu , Xiaoying Sun , Zhanhong Chen , Xiaochen Zhang , Ying Dong , Wenyan Chen , Yanxia Shi , Jing Cheng , Zhihong Mei , Fei Ma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 1103)
DOI
10.1200/JCO.2022.40.16_suppl.1103
Abstract #
1103
Poster Bd #
480
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Relationship between cognitive and emotional domains of prognostic awareness with quality of life and psychological distress in patients with advanced cancer.
First Author: Claire Greydanus
Poster
2024 ASCO Annual Meeting
A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pretreated advanced biliary tract cancer: Efficacy and safety analysis (BOLD-100-001).
First Author: Grainne M. O'Kane
Poster
2023 ASCO Quality Care Symposium
Patient-generated outcomes, questions and concerns: Quantitative and open text methods and relationships with palliative care referrals in advanced ovarian cancer.
First Author: Donna Lynn Berry
Poster
2023 ASCO Breakthrough
Risk assessment, prevention and early detection of breast cancer related lymphedema: Objective measurements and patient reported outcomes.
First Author: Anshumi Desai